NCT03876535View on ClinicalTrials.gov

Performance Evaluation of the Nanomix eLab® CRP, PCT, and LAC Assays With the Nanomix eLab System

CompletedOBSERVATIONAL
Enrollment

184

Participants

Timeline

Start Date

December 11, 2018

Primary Completion Date

April 30, 2019

Study Completion Date

August 30, 2019

Conditions
SepsisSIRS
Interventions
OTHER

Nanomix eLab® System molecular diagnostic test (non-interventional)

This is not an interventional study. It involves performance equivalence demonstration of a point of care diagnostic system to FDA cleared predicate devices currently used in sepsis and SIRS diagnosis.

Trial Locations (1)

94110

UCSF- San Francisco General Hospital, San Francisco

Sponsors

Lead Sponsor

Nanomix
All Listed Sponsors
lead

Nanomix

INDUSTRY

NCT03876535 - Performance Evaluation of the Nanomix eLab® CRP, PCT, and LAC Assays With the Nanomix eLab System | Biotech Hunter | Biotech Hunter